Equity Offerings (Details) |
12 Months Ended | |||
---|---|---|---|---|
Dec. 06, 2021
USD ($)
|
Apr. 09, 2021
USD ($)
|
Dec. 31, 2021
USD ($)
shares
|
Dec. 31, 2021
STD (Db)
shares
|
|
Proceeds from issuance of common shares, net of expenses | $ 56,060,472 | |||
Common stock issued under prospectus supplement dated December 6, 2021 | ||||
Number of shares issued during the period | shares | 10,490,188 | 10,490,188 | ||
Proceeds from issuance of common shares, net of expenses | Db | Db 56,003,751 | |||
ATM | ||||
Number of shares issued during the period | shares | 6.0 | 6.0 | ||
ATM | Common stock issued under prospectus supplement dated April 9, 2021 | ||||
Authorized Amount To Be Issued | $ 43,636,250 | |||
ATM | Common stock issued under prospectus supplement dated December 6, 2021 | ||||
Authorized Amount To Be Issued | $ 44,925,000 |
X | ||||||||||
- Definition Represents the authorized amount to be issued. No definition available.
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|